A PHASE II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF OQL011 ON VEGFR INHIBITOR-ASSOCIATED HAND-FOOT SKIN REACTION IN CANCER PATIENTS
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Supportive Care
Locations
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 19-2242
More information available at ClinicalTrials.gov: NCT04088318
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers